These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27252602)

  • 1. Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry.
    Meador W; Salter AR; Rinker JR
    Int J MS Care; 2016; 18(3):147-53. PubMed ID: 27252602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of tremor in the NARCOMS multiple sclerosis registry: a cross-sectional survey.
    Rinker JR; Salter AR; Walker H; Amara A; Meador W; Cutter GR
    BMJ Open; 2015 Jan; 5(1):e006714. PubMed ID: 25573524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey.
    Hadjimichael O; Vollmer T; Oleen-Burkey M;
    Health Qual Life Outcomes; 2008 Nov; 6():100. PubMed ID: 19014588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab.
    Rinker JR; Salter AR; Cutter GR
    Mult Scler Relat Disord; 2014 Jul; 3(4):505-12. PubMed ID: 25877063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the NARCOMS Registry: Tremor and Coordination Scale.
    Marrie RA; Goldman M
    Int J MS Care; 2011; 13(3):114-20. PubMed ID: 24453714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of multiple sclerosis symptoms.
    Kister I; Bacon TE; Chamot E; Salter AR; Cutter GR; Kalina JT; Herbert J
    Int J MS Care; 2013; 15(3):146-58. PubMed ID: 24453777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
    Chamot E; Kister I; Cutter GR
    BMC Neurol; 2014 Oct; 14():192. PubMed ID: 25278315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis.
    Marrie RA; Cutter GR; Tyry T; Cofield SS; Fox R; Salter A
    Mult Scler Relat Disord; 2017 Apr; 13():87-92. PubMed ID: 28427709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual dysfunction in patients with multiple sclerosis.
    Orasanu B; Frasure H; Wyman A; Mahajan ST
    Mult Scler Relat Disord; 2013 Apr; 2(2):117-23. PubMed ID: 25877633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NARCOMS and Other Registries in Multiple Sclerosis: Issues and Insights.
    Marrie RA; Cutter GR; Fox RJ; Vollmer T; Tyry T; Salter A
    Int J MS Care; 2021; 23(6):276-284. PubMed ID: 35035299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates and patterns of physical activity among Hispanics with multiple sclerosis in the NARCOMS Registry.
    Silveira SL; Motl RW; Marquez DX; Salter A
    Mult Scler Relat Disord; 2022 Sep; 65():104018. PubMed ID: 35810721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and risks of pharmacological treatments for essential tremor.
    Lyons KE; Pahwa R; Comella CL; Eisa MS; Elble RJ; Fahn S; Jankovic J; Juncos JL; Koller WC; Ondo WG; Sethi KD; Stern MB; Tanner CM; Tintner R; Watts RL
    Drug Saf; 2003; 26(7):461-81. PubMed ID: 12735785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A contemporary profile of primary progressive multiple sclerosis participants from the NARCOMS Registry.
    Salter A; Thomas NP; Tyry T; Cutter GR; Marrie RA
    Mult Scler; 2018 Jun; 24(7):951-962. PubMed ID: 28524746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disability in multiple sclerosis: a reference for patients and clinicians.
    Kister I; Chamot E; Salter AR; Cutter GR; Bacon TE; Herbert J
    Neurology; 2013 Mar; 80(11):1018-24. PubMed ID: 23427319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate.
    Salter A; Lancia S; Cutter G; Fox RJ; Marrie RA; Mendoza JP; Lewin JB
    Int J MS Care; 2021; 23(6):239-244. PubMed ID: 35035294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.
    Nickerson M; Marrie RA
    BMC Neurol; 2013 Sep; 13():119. PubMed ID: 24016260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical activity as a correlate of symptoms, quality of life, comorbidity, and disability status in Hispanics with multiple sclerosis.
    Silveira SL; Motl RW; Marquez DX; Lancia S; Salter A
    Disabil Health J; 2023 Apr; 16(2):101398. PubMed ID: 36402726
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.